Fig. 2From: Evaluation of dose-efficacy of sorafenib and effect of transarterial chemoembolization in hepatocellular carcinoma patients: a retrospective studyKaplan-Meier analysis of sorafenib response (a) and overall survival (b). P-value below 0.05 is considered statistically significantBack to article page